Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Sophie Perry"'
Publikováno v:
Frontiers in Education, Vol 6 (2021)
Informal science learning has great potential to engage diverse learners, but faces issues of persistent inequities. While systemic change is needed to address these issues at a structural level, there is also a need for practical tools to support th
Externí odkaz:
https://doaj.org/article/833626c9a70044498351c4d621a2374f
Publikováno v:
Frontiers in Education, Vol 6 (2021)
This paper presents a unique method for documenting and reflecting learning in interdisciplinary science learning settings, which prioritises the perspectives of marginalised learners and which may be used across cultural contexts. Short for “magaz
Externí odkaz:
https://doaj.org/article/f336fd4c56444cc98267b9609fad9bc3
Autor:
Susana Banerjee, Holly Tovey, Rebecca Bowen, Elizabeth Folkerd, Lucy Kilburn, Jennifer McLachlan, Marcia Hall, Nina Tunariu, Ayoma Attygalle, Joao Paulo Da Silveira Nogueira Lima, Sophie Perry, Peter Chatfield, Margaret Hills, Stan Kaye, Gert Attard, Mitch Dowsett, Judith M. Bliss
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Recurrent epithelial ovarian cancer (EOC) remains difficult to treat, with an urgent need for more therapy options. Androgens bind to the androgen receptor (AR), commonly expressed in EOC. CYP17 inhibitor abiraterone irreversibly inhibits
Externí odkaz:
https://doaj.org/article/573e022757c443b698c2911c247d9712
Autor:
Stephen Johnston, Judith M. Bliss, Claire Swift, Nick Turner, Chris Holcombe, Sophie Perry, Maggie Cheang, Vera Martins, Andrew Dodson, Shannon Puhalla, Melanie Finnigan, Samuel A. Jacobs, Yuan Liu, Katherine Pogue-Geile, C. Kent Osborne, Mothaffar F. Rimawi, Lucy Kilburn, Mitch Dowsett
Purpose:To determine (i) the relationship between candidate biomarkers of the antiproliferative (Ki67) response to letrozole and palbociclib alone and combined in ER+/HER2− breast cancer; and (ii) the pharmacodynamic effect of the agents on the bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2279285765c81c0e79596b56399a3d4e
https://doi.org/10.1158/1078-0432.c.6531375.v1
https://doi.org/10.1158/1078-0432.c.6531375.v1
Autor:
Stephen Johnston, Judith M. Bliss, Claire Swift, Nick Turner, Chris Holcombe, Sophie Perry, Maggie Cheang, Vera Martins, Andrew Dodson, Shannon Puhalla, Melanie Finnigan, Samuel A. Jacobs, Yuan Liu, Katherine Pogue-Geile, C. Kent Osborne, Mothaffar F. Rimawi, Lucy Kilburn, Mitch Dowsett
Supplementary Data from Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2− Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e361d5674cd4ee2e32f3d48facbc707
https://doi.org/10.1158/1078-0432.22484283
https://doi.org/10.1158/1078-0432.22484283
Autor:
Nicholas Turner, Claire Swift, Ben Jenkins, Lucy Kilburn, Maria Coakley, Matthew Beaney, Lisa Fox, Katie Goddard, Isaac Garcia-Murillas, Peter Hall, Catherine Harper-Wynne, Tamas Hickish, Sarah Kernaghan, Iain Macpherson, Alicia Okines, Carlo Palmieri, Sophie Perry, Katrina Randle, Claire Snowdon, Hilary Stobart, Andrew Wardley, Duncan Wheatley, Simon Waters, Matthew Winter, Judith Bliss
Publikováno v:
Cancer Research. 82:GS3-06
Background Detection of circulating tumour DNA (ctDNA) in patients (pts) who have completed treatment for early-stage triple negative breast cancer (TNBC) is associated with a very high risk of future relapse. Identifiying those at high risk of subse
Autor:
Andrew Dodson, Sophie Perry, Stephen R. D. Johnston, Claire Swift, Shannon Puhalla, Judith M Bliss, Melanie Finnigan, Katherine L. Pogue-Geile, Maggie C.U. Cheang, C. Kent Osborne, Yuan Liu, Lucy Kilburn, Mitch Dowsett, Vera Martins, Samuel A. Jacobs, Mothaffar F. Rimawi, Chris Holcombe, Nicholas C. Turner
Publikováno v:
Clinical Cancer Research. 28:163-174
Purpose: To determine (i) the relationship between candidate biomarkers of the antiproliferative (Ki67) response to letrozole and palbociclib alone and combined in ER+/HER2− breast cancer; and (ii) the pharmacodynamic effect of the agents on the bi
Autor:
Anwar R. Padhani, Nina Tunariu, Chris Parker, Emma Hall, Jessica Finch, Peter Chatfield, Adham Hijab, Sophie Perry, Holly Tovey, Roberto Alonzi, Dow-Mu Koh, Sebastian Curcean, Helen Stidwill, Matthew D. Blackledge, John Staffurth, Alison Tree
Publikováno v:
Clinical Genitourinary Cancer
Background Radium-223 is a bone-seeking, alpha-emitting radionuclide used in metastatic castration-resistant prostate cancer (mCRPC). Radium-223 increases the risk of fracture when used in combination with abiraterone and prednisolone. The risk of fr
Publikováno v:
Abstracts.
Autor:
Mitch, Dowsett, Lucy, Kilburn, Mothaffar F, Rimawi, C Kent, Osborne, Katherine, Pogue-Geile, Yuan, Liu, Samuel A, Jacobs, Melanie, Finnigan, Shannon, Puhalla, Andrew, Dodson, Vera, Martins, Maggie, Cheang, Sophie, Perry, Chris, Holcombe, Nick, Turner, Claire, Swift, Judith M, Bliss, Stephen, Johnston
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(1)
To determine (i) the relationship between candidate biomarkers of the antiproliferative (Ki67) response to letrozole and palbociclib alone and combined in ER307 postmenopausal women with ERHigher baselines ER and PgR were significantly associated wit